Monday May 13, 2:00 pm Eastern Time
Press Release
SOURCE: Isotechnika Inc.
Isotechnika to Webcast Annual General Meeting
Trades on Toronto Stock Exchange Symbol - (ISA - (TSE:ISA) )
www.isotechnika.com
EDMONTON, May 13 /CNW/ - In conjunction with its Annual General Meeting, Isotechnika will hold an analyst conference call and web cast on Wednesday, May 15th, 2002 at 10:00 a.m. (Eastern). The web cast will include a corporate and scientific update.
The conference call and web cast will be chaired by Dr. Robert Foster, Chairman and CEO with Dr. Randall Yatscoff presenting the scientific update. The live web cast (listen-only mode) of the Annual General Meeting and presentation will be available at webevents.broadcast.com.
Following the Annual General Meeting a recording of this web cast will be archived for a 90 day period through the web cast archives at www.newswire.ca.
About ISOTECHNIKA INC.
----------------------
Isotechnika Inc. and Roche recently signed an agreement for the global co-development and commercialization of Isotechnika's innovative transplant drug, ISA(TX)247. This agreement represents the largest Canadian drug development deal between a large pharma and a biotech company. Isotechnika Inc. is an international life sciences company headquartered in Edmonton, Alberta with additional operations in Arizona. The company is focused on the development of immunosuppressive therapeutic drugs for use in organ transplant patients and in the treatment of autoimmune diseases. Its founders and scientific team have developed a novel, multi-platform drug, ISA(TX)247, which has progressed through discovery, pre-clinical and Phase 1 human clinical trials in less than five years. ISA(TX)247 is currently undergoing Phase 2 human clinical trials in renal transplantation and psoriasis and has the potential to become the market leader in immunosuppressant therapy; an established market for drugs of this class is in excess of 2.2 billion USD per year globally. Isotechnika Inc. is an S&P/TSX Composite Index company publicly traded under the symbol ISA. More information on Isotechnika can be found at www.isotechnika.com
For further information
Gordon Agopsowicz, Director, Investor Relations, Isotechnika Inc., (780) 487-1600 Ext. 245, (780) 484-4105 (fax), gagopsowicz@isotechnika.com
Archived images on this organization are available through CNW E-Pix at newswire.ca. Images are free to members of The Canadian Press. |
